<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599813488752</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599813488752</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Head and Neck Surgery</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Is Montgomery Tracheal Safe-T-Tube Clinical Failure Induced by Biofilm?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Fusconi</surname><given-names>Massimo</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488752">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lo Vasco</surname><given-names>Vincenza Rita</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488752">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Delfini</surname><given-names>Andrea</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0194599813488752">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>De Virgilio</surname><given-names>Armando</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488752">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Taddei</surname><given-names>Anna Rita</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599813488752">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vassalli</surname><given-names>Carlo</given-names></name>
<xref ref-type="aff" rid="aff3-0194599813488752">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Conte</surname><given-names>Michela</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488752">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Del Sette</surname><given-names>Fausto</given-names></name>
<xref ref-type="aff" rid="aff3-0194599813488752">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Benincasa</surname><given-names>Anna Teresa</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488752">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>de Vincentiis</surname><given-names>Marco</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488752">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599813488752">
<label>1</label>Department of Sensory Organs, “Sapienza” University of Rome, Italy</aff>
<aff id="aff2-0194599813488752">
<label>2</label>Interdepartmental Centre of Electron Microscopy (C.I.M.E.), Tuscia University, Viterbo, Italy</aff>
<aff id="aff3-0194599813488752">
<label>3</label>Astronautic, Electrical and Energy Engineering Department, “Sapienza” University of Rome, Italy</aff>
<author-notes>
<corresp id="corresp1-0194599813488752">Armando De Virgilio, MD, Department of Sensory Organs, “Sapienza” University of Rome, Viale del Policlinico 155, 00100, Rome, Italy. Email: <email>armando.devirgilio@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>149</volume>
<issue>2</issue>
<fpage>269</fpage>
<lpage>276</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>1</month>
<year>2013</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>3</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>4</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599813488752">
<title>Objectives</title>
<p>Montgomery Safe-T-Tube deterioration and early biofilm colonization may explain the discomfort claimed by many patients and clinical failures. The aim of the study was to analyze the deterioration of Montgomery Safe-T-Tube morphological and mechanical properties in vivo in 16 patients by using microbiological methods, optical and electron microscopy, and engineering tests.</p>
</sec>
<sec id="section2-0194599813488752">
<title>Study Design</title>
<p>Prospective controlled study at a single medical center.</p>
</sec>
<sec id="section3-0194599813488752">
<title>Setting</title>
<p>University hospital.</p>
</sec>
<sec id="section4-0194599813488752">
<title>Subjects and Methods</title>
<p>The study, conducted from April 2007 to February 2012 at the “Sapienza” University of Rome, was designed to collect 2 Montgomery Safe-T-Tubes from each patient. The first was removed 3 to 15 days after insertion (group A) and the second at least 90 days after (group B). Specimens underwent microbiologic assays, electron microscopic analysis, immunocytologic analysis, and mechanical tests.</p>
</sec>
<sec id="section5-0194599813488752">
<title>Results</title>
<p>Microorganisms were not isolated in 2 group A cases (12%), whereas they were in all group B cases. Biofilm was identified in 11 of 16 (69%) group A samples and in 16 of 16 (100%) group B samples (<italic>P</italic> = .0149) using scanning electron microscopy. Immunohistochemistry showed monocyte-granulocyte line cells producing interleukin-1β on the external surfaces of Montgomery Safe-T-Tubes. The tensile test showed that the wear related to the longer period of use makes Montgomery Safe-T-Tubes more rigid than newer ones.</p>
</sec>
<sec id="section6-0194599813488752">
<title>Conclusion</title>
<p>Early biofilm colonization takes place in Montgomery Safe-T-Tubes in most cases. The mechanical decay could be justified in part by the destructive biofilm activity and by the release of inflammatory effectors and enzymes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Montgomery Safe-T-tube</kwd>
<kwd>laryngeal stenosis</kwd>
<kwd>biofilm</kwd>
<kwd>tensile test</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Montgomery Safe-T-Tube (MTT) insertion is a commonly used conservative management strategy that may be applied as a single-dilation treatment or in association with endoscopic and/or open-neck surgery in patients affected by benign laryngotracheal stenosis.<sup><xref ref-type="bibr" rid="bibr1-0194599813488752">1</xref>,<xref ref-type="bibr" rid="bibr2-0194599813488752">2</xref></sup> Montgomery Safe-T-Tubes have a number of advantages over exclusively endoluminal stents, which include (1) easier clearance of secretions and cleansing through the external arm, (2) extremely limited risk of migration, and (3) the possibility of verifying stent patency during follow-up with a flexible laryngoscope.<sup><xref ref-type="bibr" rid="bibr3-0194599813488752">3</xref></sup> Inexplicably, studies on the clinical applications of MTT are not numerous, and an encoded guideline on the use of MTT in ear, nose, and throat clinical practice most likely does not exist for this reason.</p>
<p>Our experience involves 169 MTT insertions in 72 patients from 1990 to 2012. In more than 50% of cases, patients complained of progressive difficulty in MTT management (greater difficulty in swallowing, increase in the frequency of obstructions, and foreign body sensation).</p>
<p>As in all silicone devices, MTT undergoes wear and is exposed to colonization by bacilli and fungi organized in biofilms (matrix-enclosed bacterial populations adherent to each other and/or to surfaces or interfaces<sup><xref ref-type="bibr" rid="bibr4-0194599813488752">4</xref></sup>). However, this phenomenon has not yet been studied or quantified. The aim of our study was to analyze the deterioration of MTT morphologic and mechanical properties using microbiological methods, optical and electron microscopy, and engineering tests.</p>
<sec id="section7-0194599813488752" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>The Medical Ethics Committee of “La Sapienza” University of Rome approved the study protocol. Thoracic nonradiopaque MTTs (Boston Medical Products, Westborough, Massachusetts) were positioned in patients with laryngeal stenosis who underwent CO<sub>2</sub> laser laryngeal airway enlargement. The shorter arm was positioned on the tracheal side, whereas the longer one was used for the laryngeal side, allowing us to shorten the upper extension as desired.</p>
<sec id="section8-0194599813488752">
<title>Study Design</title>
<p>The prospective study was designed to collect 2 MTTs from each patient. The first was removed due to dysphagia or inhalation caused by excessive upper arm length 3 to 15 days after initial placement (group A). The second MTT was removed at least 90 days after its placement (group B). Montgomery Safe-T-Tubes were removed with conventional curved Klemmer forceps through the tracheostomy and placed in sterile containers. Consequently, each enrolled patient underwent a first involuntary unsuccessful surgical procedure and a second successful one. Patients who did not meet these criteria were excluded from the study.</p>
<p>Specimens underwent microbiologic assays, electron microscopic analysis, immunocytologic analysis, and mechanical tests. The superior MTT arm was split into 3 pieces (1 for the microbiologic assays, 1 for the electron microscope analysis, and 1 for the immunocytologic analysis), whereas the inferior one was used for the mechanical tests.</p>
</sec>
<sec id="section9-0194599813488752">
<title>Patients</title>
<p>From April 2007 to February 2012, 43 patients underwent endoscopic laser airspace enlargement and MTT insertion. Among them, 16 patients met the inclusion criteria and were prospectively enrolled (<xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>). We used 13 mmØ MTT in 8 patients (50%), 12 mmØ in 5 cases (31%), and 12 mmØ in 3 cases (19%). We formed 2 groups (group A and group B) composed of 16 MTT each (<xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>).</p>
<table-wrap id="table1-0194599813488752" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical and microbiologic data on Montgomery Safe-T-Tubes (MTTs).</p>
</caption>
<graphic alternate-form-of="table1-0194599813488752" xlink:href="10.1177_0194599813488752-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Patient</th>
<th align="center">First MTT Duration, d</th>
<th align="center">Biofilm</th>
<th align="center">Bacteria</th>
<th align="center">Fungi</th>
<th align="center">Second MTT Duration, d</th>
<th align="center">Biofilm</th>
<th align="center">Bacteria</th>
<th align="center">Fungi</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>7</td>
<td>Present</td>
<td>
<italic>Staphylococcus intermedius</italic>
</td>
<td>
<italic>Candida tropicalis</italic>
</td>
<td>98</td>
<td>Present</td>
<td>
<italic>Streptococcus pyogenes</italic>
</td>
<td>
<italic>Candida tropicalis</italic>
</td>
</tr>
<tr>
<td>2</td>
<td>8</td>
<td>Present</td>
<td>
<italic>Streptococcus suis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>160</td>
<td>Present</td>
<td>
<italic>Streptococcus suis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>3</td>
<td>3</td>
<td>Absent</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>—</td>
<td>124</td>
<td>Present</td>
<td>
<italic>Escherichia coli</italic>
</td>
<td>
<italic>Candida humicola</italic>
</td>
</tr>
<tr>
<td>4</td>
<td>7</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>156</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida krusei</italic>
</td>
</tr>
<tr>
<td>5</td>
<td>11</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>100</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>6</td>
<td>7</td>
<td>Present</td>
<td>
<italic>Escherichia coli</italic>
</td>
<td>
<italic>Candida glabrata</italic>
</td>
<td>95</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida glabrata</italic>
</td>
</tr>
<tr>
<td>7</td>
<td>10</td>
<td>Present</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>161</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>8</td>
<td>8</td>
<td>Absent</td>
<td>
<italic>Staphylococcus cohnii</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>123</td>
<td>Present</td>
<td>
<italic>Streptococcus pyogenes</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>9</td>
<td>13</td>
<td>Present</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>124</td>
<td>Present</td>
<td>—</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>10</td>
<td>3</td>
<td>Absent</td>
<td>—</td>
<td>—</td>
<td>94</td>
<td>Present</td>
<td>
<italic>Escherichia coli</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>11</td>
<td>12</td>
<td>Present</td>
<td>—</td>
<td>
<italic>Candida glabrata</italic>
</td>
<td>111</td>
<td>Present</td>
<td>—</td>
<td>
<italic>Candida glabrata</italic>
</td>
</tr>
<tr>
<td>12</td>
<td>11</td>
<td>Present</td>
<td>
<italic>Staphylococcus aureus</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>145</td>
<td>Present</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>13</td>
<td>3</td>
<td>Absent</td>
<td>—</td>
<td>—</td>
<td>127</td>
<td>Present</td>
<td>
<italic>Streptococcus pyogenes</italic>
</td>
<td>
<italic>Candida tropicalis</italic>
</td>
</tr>
<tr>
<td>14</td>
<td>4</td>
<td>Absent</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>—</td>
<td>157</td>
<td>Present</td>
<td>
<italic>Streptococcus salivarius</italic>
</td>
<td>
<italic>Candida tropicalis</italic>
</td>
</tr>
<tr>
<td>15</td>
<td>14</td>
<td>Present</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>144</td>
<td>Present</td>
<td>
<italic>Streptococcus salivarius</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td>16</td>
<td>9</td>
<td>Present</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
<td>136</td>
<td>Present</td>
<td>
<italic>Staphylococcus epidermidis</italic>
</td>
<td>
<italic>Candida albicans</italic>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599813488752">
<p>—, not isolated.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Of the 16 patients enrolled in the study, 13 (81%) were male and 3 (19%) were female. Median age was 57 years. All patients underwent CO<sub>2</sub> laser laryngeal airway enlargement and MTT insertion through suspension microlaryngoscopy. Seven patient<italic>s</italic> (44%) underwent surgery for neoglottic stenosis after supracricoid partial laryngectomy, 4 patients (25%) for congenital laryngeal stenosis, 3 (19%) for iatrogenic vocal cord paralysis, and 2 (12%) for stenosis after laryngeal laser surgery for early mali<italic>g</italic>nant diseases.</p>
</sec>
<sec id="section10-0194599813488752">
<title>Microbiology</title>
<p>Since patients undergoing subtotal laryngectomy are chronic inhalers of oropharyngeal contents, we should emphasize that the bacterial load to which MTTs are exposed in these patients is greater than in those with other forms of laryngeal stenosis. However, since these patients had different degrees of inhalation (including very slight inhalation degrees), we did not differentiate them in our study for statistical purposes.</p>
<p>“Scraping” of the outer surfaces was performed. The isolated microorganisms were diluted in reduced transport fluid and plated on brain-heart infusion agar plates for yeasts and blood agar plates for bacteria. After 3 days at 37°C in an aerobic incubator, microorganisms were distinguished on the basis of visual inspection and subcultured.</p>
<p>Once pure fungal and bacterial cultures were obtained, the yeast strains were identified by the ID 32°C identification system (BioMérieux, Marcy-l’Etoile, France), and bacteria were first examined using light microscopy and Gram staining. Subsequently, the bacterial strains were identified by the GP MicroPlate (Biolog, Hayward, California) for Gram-positive bacteria and by the GN MicroPlate (Biolog) for Gram-negative bacteria.</p>
</sec>
<sec id="section11-0194599813488752">
<title>Electron Microscopy</title>
<p>Thirty-two specimens were prepared for scanning electron microscopy (SEM) at the Interdisciplinary Centre for Electron Microscopy (CIME) of the University of Tuscia following traditional procedures described in our previous studies.<sup><xref ref-type="bibr" rid="bibr5-0194599813488752">5</xref>,<xref ref-type="bibr" rid="bibr6-0194599813488752">6</xref></sup>
</p>
</sec>
<sec id="section12-0194599813488752">
<title>Immunohistochemistry</title>
<p>Scraping of the 16 group B MTTs was performed, obtaining fragments that were fixed with 4% paraformaldehyde and embedded in paraffin. Sections were stained with hematoxylin and eosin and Gram stain. Additional sections were analyzed by the immunocytochemical method with the following primary antibodies: monoclonal antibody monocyte + granulocyte antibody (mouse) FITC conjugated (cat ab24885; Abcam, Cambridge, Massachusetts), conjugated with the fluorescent dye fluorescein, interleukin (IL)–1β antibody (cat ab2105; Abcam), and Lymphocyte Activation Gene 3 antibody (cat ab40466; Abcam). Immunohistochemistry was performed only in group B patients since group A MTTs were positioned less than 15 days before. Therefore, although we performed immunohistochemistry and isolated inflammatory cells, we could not discriminate whether their presence was due to surgical trauma or to the MTT itself.</p>
</sec>
<sec id="section13-0194599813488752">
<title>Tensile Test</title>
<p>Twenty inferior arm specimens collected from the last 10 consecutive patients (patients 1-10) (<xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>) underwent the tensile test with the aim of evaluating MTT mechanical property degradation using the HBM-U2B tester (Schenck Trebel, Deer Park, New York). A single tensile test was also performed on a new MTT and the obtained value was used as control (<xref ref-type="fig" rid="fig1-0194599813488752"><bold>Figure 1a</bold></xref>). The test consists of applying an increasing tangential force to the sample, which is responsible for a transverse displacement, until it reaches the breaking point. The parameters taken into consideration are the break load (force responsible for the rupture of the specimen, expressed in kN on the y-axis) and the transverse displacement (the maximum elongation, expressed in mm on the x-axis) (<xref ref-type="fig" rid="fig1-0194599813488752"><bold>Figure 1b</bold></xref>, <xref ref-type="fig" rid="fig1-0194599813488752"><bold>c</bold></xref>). Data were collected using a Metro Com Data Acquisition System (Metro Com Engineering Spa, Garbagna Novarese, Italy). Calibration of all components was certified by the SIT calibration center (Garbagna Novarese, Italy).</p>
<fig id="fig1-0194599813488752" position="float">
<label>Figure 1.</label>
<caption>
<p>Scanning electron microscopy findings: (a) Montgomery Safe-T-Tube surface covered with biofilms. (b, c) Fungal and bacterial aggregates at higher magnification. (d) Isolated bacterial colonies.</p>
</caption>
<graphic xlink:href="10.1177_0194599813488752-fig1.tif"/>
</fig>
</sec>
<sec id="section14-0194599813488752">
<title>Statistical Analysis</title>
<p>Statistical analysis was performed using SPSS for Windows version 15.0 (SPSS, Inc, an IBM Company, Chicago, Illinois). Comparison of results was performed using the Student <italic>t</italic> test or χ<sup>2</sup> test according to the characteristics of the data. <italic>P</italic> &lt; .05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="section15-0194599813488752" sec-type="results">
<title>Results</title>
<sec id="section16-0194599813488752">
<title>Patients</title>
<p>All patients reported increasing foreign body sensation (100%), 10 reported progressive dyspnea (62%), 9 patients reported moderate dysphagia (56%), and 6 presented with local swelling and cervical constriction sensation (37%). In 3 patients (19%), MTT was removed due to intolerance (patients 1, 6, and 16; <xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>).</p>
<p>After MTT removal, no further treatments were required in 9 patients (56%) and decannulation was performed. One month after MTT removal, 4 patients (25%) had a tracheal cannula in place and were able to maintain it closed during the day. In 3 patients (19%), a second surgical attempt was scheduled approximately 30 days after MTT removal due to the formation of a new glottic/neoglottic stenosis.</p>
</sec>
<sec id="section17-0194599813488752">
<title>Microbiology</title>
<p>Main results are reported in <xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>. In group A, the most represented isolated bacteria were <italic>Staphylococcus epidermidis</italic> (6 cases; 38%). In group A, the most isolated fungus was <italic>Candida albicans</italic> (9 cases; 56%). In group B, most represented bacteria were <italic>Staphylococcus aureus</italic> (4 cases; 25%), and the most isolated fungus was again <italic>C albicans</italic> (9 cases; 56%).</p>
</sec>
<sec id="section18-0194599813488752">
<title>Electron Microscopy</title>
<p>With SEM, the biofilm was identified in 11 of 16 (69%) group A samples and in 16 of 16 (100%) group B samples. The difference was statistically relevant with a χ<sup>2</sup> test (<italic>P</italic> = .014, 1 degree of freedom). Of the 5 group A patients in which the biofilm was not identified, 3 had undergone MTT placement for post-supracricoid laryngectomy neolaryngeal stenosis (43% of the supracricoid laryngectomy cases), 1 for congenital laryngeal stenosis (25% of the congenital laryngeal stenosis cases), and 1 for iatrogenic vocal cord paralysis (33% of the iatrogenic vocal cord paralysis cases). With SEM, when the biofilm was identified, the MTT surface was coated by aggregates of fungi and bacteria organized at the edges (<xref ref-type="fig" rid="fig2-0194599813488752"><bold>Figure 2a</bold></xref>, <xref ref-type="fig" rid="fig2-0194599813488752"><bold>b</bold></xref>). In areas where aggregates were not very compact, we could identify individual bacteria (<xref ref-type="fig" rid="fig2-0194599813488752"><bold>Figure 2c</bold></xref>, <xref ref-type="fig" rid="fig2-0194599813488752"><bold>d</bold></xref>). In some samples, the MTT inner surface was covered by yeast colonies densely arranged and packed to form dome-like structures<sup><xref ref-type="bibr" rid="bibr7-0194599813488752">7</xref></sup> (<xref ref-type="fig" rid="fig3-0194599813488752"><bold>Figure 3a</bold></xref>). <xref ref-type="fig" rid="fig3-0194599813488752"><bold>Figure 3b</bold></xref> shows a transverse cutting of the tube, with colonies sneaking into the structure defect. It is not clear whether the defect is an MTT imperfection or is caused by biofilm. Lymphocytes and macrophages were also identified on the external laryngotracheal MTT surface (<xref ref-type="fig" rid="fig3-0194599813488752"><bold>Figure 3c</bold></xref>, <xref ref-type="fig" rid="fig3-0194599813488752"><bold>d</bold></xref>).</p>
<fig id="fig2-0194599813488752" position="float">
<label>Figure 2.</label>
<caption>
<p>Scanning electron microscopy findings: (a) yeast dome-like structures, (b) yeast colonies sneaking into the structure defect, (c) lymphocytes, and (d) and macrophages on the Montgomery Safe-T-Tube external surface.</p>
</caption>
<graphic xlink:href="10.1177_0194599813488752-fig2.tif"/>
</fig>
<fig id="fig3-0194599813488752" position="float">
<label>Figure 3.</label>
<caption>
<p>Optical microscopy of Montgomery Safe-T-tube scraping (hematoxylin and eosin staining): (a) bacterial groups (×20) and (b) lymphocytes (arrows, ×40).</p>
</caption>
<graphic xlink:href="10.1177_0194599813488752-fig3.tif"/>
</fig>
</sec>
<sec id="section19-0194599813488752">
<title>Immunohistochemistry</title>
<p>Histologic examination of the aggregate on the external side of the prosthesis (laryngotracheal side) showed modest cellularity partly amenable to lymphocytes in 15 of 16 prostheses (94%) (<xref ref-type="fig" rid="fig4-0194599813488752"><bold>Figure 4a</bold></xref>, <xref ref-type="fig" rid="fig4-0194599813488752"><bold>b</bold></xref>).</p>
<fig id="fig4-0194599813488752" position="float">
<label>Figure 4.</label>
<caption>
<p>Immunohistochemical analysis: (a, b) FITC marked cells (green), (c, d) Alexa Fluor marked cells (red,), and (e, f) merged image showing that the monocyte/granulocyte lineage produces interleukin-1β (×40).</p>
</caption>
<graphic xlink:href="10.1177_0194599813488752-fig4.tif"/>
</fig>
<p>Immunohistochemical analysis revealed the presence of cells of the monocyte-granulocyte in 15 of 15 (100%) patients (<xref ref-type="fig" rid="fig5-0194599813488752"><bold>Figure 5a</bold></xref>, <xref ref-type="fig" rid="fig5-0194599813488752"><bold>b</bold></xref>), IL-1β–producing cells in 14 of 15 (93%) specimens (<xref ref-type="fig" rid="fig5-0194599813488752"><bold>Figure 5c</bold></xref>, <xref ref-type="fig" rid="fig5-0194599813488752"><bold>d</bold></xref>), and activated lymphocytes in 14 of 15 (93%) patients. The overlap of the acquired images showed that the cells producing IL-1β coincide with the cells of the monocyte-granulocyte line (<xref ref-type="fig" rid="fig5-0194599813488752"><bold>Figure 5e</bold></xref>, <xref ref-type="fig" rid="fig5-0194599813488752"><bold>f</bold></xref>).</p>
<fig id="fig5-0194599813488752" position="float">
<label>Figure 5.</label>
<caption>
<p>Tensile test: (a) group A sample, (b) Schenck-Trebel test system, (c) group B sample, and tensile test of group A (d) and group B (e) samples.</p>
</caption>
<graphic xlink:href="10.1177_0194599813488752-fig5.tif"/>
</fig>
</sec>
<sec id="section20-0194599813488752">
<title>Tensile Test</title>
<p>Main results are reported in <xref ref-type="table" rid="table2-0194599813488752"><bold>Table 2</bold></xref> and test samples are reported in <xref ref-type="fig" rid="fig5-0194599813488752"><bold>Figure 5</bold></xref>. The mean (SD) break load was 0.322 (0.018) for group A and 0.303 (0.016) for group B. The difference was not statistically relevant with the Student <italic>t</italic> test (<italic>P</italic> = .589), and average values did not differ from those obtained from the control.</p>
<table-wrap id="table2-0194599813488752" position="float">
<label>Table 2.</label>
<caption>
<p>Tensile test results.</p>
</caption>
<graphic alternate-form-of="table2-0194599813488752" xlink:href="10.1177_0194599813488752-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Average Break Load, kN</th>
<th align="center">
<italic>P</italic> Value</th>
<th align="center">Mean Transverse Displacement, mm</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Group A</td>
<td>.322</td>
<td/>
<td>191.97</td>
<td/>
</tr>
<tr>
<td>Group B</td>
<td>.303</td>
<td>.589</td>
<td>146.98</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Control (1 specimen)</td>
<td>.317</td>
<td/>
<td>195.12</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>The mean (SD) transverse displacement was 191.97 (13.42) mm for group A and 146.98 (15.22) mm for group B. The difference between groups was statistically significant with the Student <italic>t</italic> test (<italic>P</italic> &lt; .001), and group A values were more similar to the control sample than group B values (<xref ref-type="table" rid="table2-0194599813488752"><bold>Table 2</bold></xref>).</p>
</sec>
</sec>
<sec id="section21-0194599813488752" sec-type="discussion">
<title>Discussion</title>
<p>The MTT, first described by Montgomery in 1964,<sup><xref ref-type="bibr" rid="bibr8-0194599813488752">8</xref></sup> is still used in many centers for the treatment of laryngotracheal stenosis. Its function is to maintain patency of the respiratory tract in patients undergoing open or endoscopic surgical airway enlargement such as CO<sub>2</sub> laser cordectomy or supracricoid laryngectomies.<sup><xref ref-type="bibr" rid="bibr8-0194599813488752">8</xref><xref ref-type="bibr" rid="bibr9-0194599813488752"/>-<xref ref-type="bibr" rid="bibr10-0194599813488752">10</xref></sup></p>
<p>However, a silicone prosthesis is a foreign body and may be responsible for infection or granulation tissue formation, and in some cases, MTT removal is necessary due to the patient’s intolerance. In the literature, MTT failure rates above 10% are reported.<sup><xref ref-type="bibr" rid="bibr11-0194599813488752">11</xref></sup> Moreover, even when MTT removal is not necessary, it causes subclinic local infection and/or inflammation, which is likely responsible for the progressive discomfort referred by approximately 50% of patients in our experience.<sup><xref ref-type="bibr" rid="bibr1-0194599813488752">1</xref></sup> Most of the patients complained of an increasing foreign body sensation since MTT mechanically stimulates laryngeal mucosa. The aberrant stimulation of laryngeal and hypopharyngeal mucosal receptors may also be responsible for uncoordinated deglutition and dysphagia. Montgomery Safe-T-Tubes may also be responsible for the cervical constriction sensation since it causes chronic local inflammation and swelling. Furthermore, the progressive accumulation of secretions and organic material, hardly removable with common cleansing strategies, causes progressive MTT lumen narrowing with development of dyspnea.</p>
<p>These considerations are supported by our data: all patients reported an increasing foreign body sensation, 62% reported progressive dyspnea, 56% referred to moderate dysphagia, and 37% presented with local swelling and cervical constriction. Furthermore, in 19% of the patients, MTT was removed due to intolerance.</p>
<p>These events led us to investigate the causes of these phenomena since, to the best of our knowledge, there are no studies on this particular type of device in the literature.</p>
<p>Montgomery Safe-T-Tubes should be inserted in a virtually sterile region, which becomes at risk of direct and indirect contamination through the oropharyngeal and/or the trans-tracheostomal airways.<sup><xref ref-type="bibr" rid="bibr12-0194599813488752">12</xref></sup> From studies reported in the literature, we know that silicone implants trigger an immune system reaction with local recruitment of macrophages. In the early stages, they are also responsible for phagocytosis of bacteria, which in the initial phases avoids biofilm colonization. Inevitably, biofilm does eventually develop, and it turns out to be co-responsible for a chronic local inflammatory response.<sup><xref ref-type="bibr" rid="bibr13-0194599813488752">13</xref></sup>
</p>
<p>To investigate this phenomenon and its eventual consequences on MTT mechanical properties, we performed microbiologic analyses, electron microscopy, immunohistochemistry, and biomechanical tests. These approaches enabled us to evaluate (a) the presence of bacteria and fungi (microbiology), (b) their spatial organization (SEM), (c) the presence and distribution of inflammatory cells (SEM and immunohistochemistry), and (d) MTT mechanical property decay. However, it should be disclosed that confocal laser scanning microscopy with electron microscopy for validation is standard of care in biofilm studies. Consequently, a potential bias has been introduced since confocal laser scanning microscopy would give more information on the spatial distribution of bacteria, particularly on the z-axis.</p>
<p>Our study focused on the external MTT surface, which is in direct contact with the laryngotracheal mucosa. Montgomery Safe-T-Tube sample cultures of the lower branch showed interesting results: although in all group B samples, it was possible to isolate microorganisms (bacteria or fungi), it was possible in 14 of 16 cases (87%) in group A. This highlights the fact that the MTT is colonized by microorganisms and especially from fungi just a few days after insertion (<xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>). In 4 of 5 (80%) group A patients, we could not identify biofilm or fungi. Furthermore, when biofilm was identified, fungi were always present. This evidence supports the hypothesis that fungal colonization could be the first step in biofilm growth.</p>
<p>Of the 5 group A patients in which the biofilm was not identified, 3 had MTT placement for post-supracricoid laryngectomy neolaryngeal stenosis, 1 for congenital laryngeal stenosis, and 1 for iatrogenic vocal cord paralysis. For this reason, we can assume that biofilm growth did not prove to be related to the etiology of the stenosis.</p>
<p>The isolated bacterial flora proves to be highly heterogeneous and probably reflects the possibility of colonization by potentially pathogenic or saprophytic oropharyngeal bacteria (<italic>Streptococcus salivarius, Streptococcus pyogenes</italic>) but also from cutaneous microorganisms through tracheostomy (<italic>Staphylococcus epidermidis</italic>).</p>
<p>With SEM, biofilm was identified in 69% of group A samples and in 100% of group B samples, bringing out a statistically relevant difference with the χ<sup>2</sup> test (<italic>P</italic> = .014) (<xref ref-type="table" rid="table1-0194599813488752"><bold>Table 1</bold></xref>). This aspect highlights the fact that the incidence of biofilm formation appears to be related to the MTT residence time. From some details, it is possible to speculate that these aggregates cause structural damage to the silicone polymer. Cross sections performed at the fungal dome level seem to reveal polymer biofilm erosion (<xref ref-type="fig" rid="fig3-0194599813488752"><bold>Figure 3b</bold></xref>). However, it is unclear whether the defect is caused by biofilms or whether it is an MTT construction defect. Furthermore, it was also possible to observe the presence of immune system cells such as lymphocytes and macrophages (<xref ref-type="fig" rid="fig3-0194599813488752"><bold>Figure 3c</bold></xref>, <xref ref-type="fig" rid="fig3-0194599813488752"><bold>d</bold></xref>).</p>
<p>These issues were confirmed via light microscopy and immunohistochemistry. In these sections, immunohistochemistry confirmed the presence of monocyte line cells (macrophages) secreting IL-1β, which is an inflammatory cytokine produced in the early stages of inflammation (<xref ref-type="fig" rid="fig5-0194599813488752"><bold>Figure 5</bold></xref>). In addition, we identified activated lymphocytes. Therefore, on the external side of the prosthesis, an inflammatory reaction is present. The latter, together with the possible destructive behavior of biofilm, may be responsible for the MTT mechanical properties decay shown with the tensile test. In fact, group B MTTs presented a statistically significant reduction of the elastic properties measured as average transverse displacement (Student <italic>t</italic> test, <italic>P</italic> &lt; .001) (<xref ref-type="table" rid="table2-0194599813488752"><bold>Table 2</bold></xref>). This means that MTT progressively loses its softness and ability to endure the forces and the deformation imposed by the surrounding structures.</p>
<p>In our series, complete success was achieved in only 56% of patients, and 44% still needed a tracheal cannula. In addition, in 19% of cases, a new surgical attempt was scheduled within 30 days of MTT removal.</p>
<p>Before this study, we believed that the longer the device was kept, the more stable and consolidated the surgical airspace enlargement would be. On the basis of this experience, we actually believe that the MTT should be kept in place for a limited time since biofilm colonization and the mechanical stress due to the increased rigidity of the MTT are responsible for a chronic inflammatory reaction that can potentially compromise functional outcome. In our opinion, to better investigate the latter aspect, further studies relating clinical outcomes to MTT removal time are needed.</p>
<p>Furthermore, our data support the need to develop new antifouling biomaterials or new antimicrobial agents. Biofilm growth could be inhibited by incorporating antimicrobial materials on the surface or into the silicone matrix by using metal coating techniques (eg, silver, gold, titanium),<sup><xref ref-type="bibr" rid="bibr14-0194599813488752">14</xref></sup> a glow discharge plasma treatment,<sup><xref ref-type="bibr" rid="bibr15-0194599813488752">15</xref></sup> adsorption of fluorocarbons (Teflon),<sup><xref ref-type="bibr" rid="bibr16-0194599813488752">16</xref></sup> functionalization of the silicone rubber surface with quaternary ammonium,<sup><xref ref-type="bibr" rid="bibr17-0194599813488752">17</xref></sup> and the use of surface active biosurfactants.<sup><xref ref-type="bibr" rid="bibr18-0194599813488752">18</xref></sup> Furthermore, biofilms could be inhibited by using prophylactic treatments such as probiotics,<sup><xref ref-type="bibr" rid="bibr19-0194599813488752">19</xref></sup> dairy products,<sup><xref ref-type="bibr" rid="bibr20-0194599813488752">20</xref></sup> caffeinated soft drinks,<sup><xref ref-type="bibr" rid="bibr21-0194599813488752">21</xref></sup> antifungal agents,<sup><xref ref-type="bibr" rid="bibr22-0194599813488752">22</xref></sup> or salivary peptides.<sup><xref ref-type="bibr" rid="bibr23-0194599813488752">23</xref></sup> However, none of the reported strategies has been studied or applied to MTT. In our opinion, the introduction of these new biomaterials could potentially improve the patient’s tolerance and quality of life, treatment effectiveness, and the device’s resistance.</p>
</sec>
<sec id="section22-0194599813488752" sec-type="conclusions">
<title>Conclusion</title>
<p>The MTT mechanical decay could be justified at least in part by the biofilm activity and by the release of inflammatory effectors and enzymes. Such events may explain the discomfort claimed by many patients and the MTT failure reported in the literature. Possibly, the same phenomena, in addition to other local and systemic factors, may be responsible for superinfection and granulation tissue formation in some patients, thus requiring removal of the MTT prematurely.<sup><xref ref-type="bibr" rid="bibr2-0194599813488752">2</xref>,<xref ref-type="bibr" rid="bibr3-0194599813488752">3</xref>,<xref ref-type="bibr" rid="bibr24-0194599813488752">24</xref></sup>
</p>
</sec>
<sec id="section23-0194599813488752">
<title>Author Contributions</title>
<p><bold>Massimo Fusconi</bold>, interpretation of data, drafting manuscript, final approval; <bold>Vincenza Rita Lo Vasco</bold>, analysis and interpretation of data, drafting manuscript, final approval; <bold>Andrea Delfini</bold>, acquisition of data, drafting manuscript; <bold>Armando De Virgilio</bold>, study design, drafting of the manuscript, final approval; <bold>Anna Rita Taddei</bold>, acquisition of data, drafting manuscript, final approval; <bold>Carlo Vassalli</bold>, analysis and interpretation of data, final approval; <bold>Michela Conte</bold>, analysis and interpretation of data, drafting manuscript, final approval; <bold>Fausto Del Sette</bold>, acquisition of data, drafting manuscript, final approval; <bold>Anna Teresa Benincasa</bold>, revision of the manuscript, final approval; <bold>Marco de Vincentiis</bold>, analysis and interpretation of data, drafting manuscript, final approval.</p>
</sec>
<sec id="section24-0194599813488752">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> Grant from the National Institutes of Health, which had no role in the study.</p>
</sec>
</body>
<back>
<ack>
<p>We are grateful to Maria Grazia Saladino for her valuable contribution in the editing of the manuscript.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599813488752">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montgomery</surname><given-names>WW</given-names></name>
<name><surname>Montgomery</surname><given-names>SK</given-names></name>
</person-group>. <article-title>Manual for use of Montgomery laryngeal, tracheal, and esophageal prostheses: update 1990</article-title>. <source>Ann Otol Rhinol Laryngol Supp</source>. <year>1990</year>;<volume>150</volume>:<fpage>2</fpage>-<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr2-0194599813488752">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herrington</surname><given-names>HC</given-names></name>
<name><surname>Weber</surname><given-names>SM</given-names></name>
<name><surname>Andersen</surname><given-names>PE</given-names></name>
</person-group>. <article-title>Modern management of laryngotracheal stenosis</article-title>. <source>Laryngoscope</source>. <year>2006</year>;<volume>116</volume>:<fpage>1553</fpage>-<lpage>1557</lpage>.</citation>
</ref>
<ref id="bibr3-0194599813488752">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gallo</surname><given-names>A</given-names></name>
<name><surname>Pagliuca</surname><given-names>G</given-names></name>
<name><surname>Greco</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Laryngotracheal stenosis treated with multiple surgeries: experience, results and prognostic factors in 70 patients</article-title>. <source>Acta Otorhinolaryngol Ital</source>. <year>2012</year>;<volume>32</volume>:<fpage>182</fpage>-<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr4-0194599813488752">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Costerton</surname><given-names>JW</given-names></name>
<name><surname>Lewandowski</surname><given-names>Z</given-names></name>
<name><surname>Caldwell</surname><given-names>DE</given-names></name>
<name><surname>Korber</surname><given-names>DR</given-names></name>
<name><surname>Lappin-Scott</surname><given-names>HM</given-names></name>
</person-group>. <article-title>Microbial biofilms</article-title>. <source>Annu Rev Microbiol</source>. <year>1995</year>;<volume>49</volume>:<fpage>711</fpage>-<lpage>745</lpage>.</citation>
</ref>
<ref id="bibr5-0194599813488752">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fusconi</surname><given-names>M</given-names></name>
<name><surname>Chiarini</surname><given-names>F</given-names></name>
<name><surname>Taddei</surname><given-names>AR</given-names></name>
<etal/>
</person-group>. <article-title>Chemical ear peeling: a simple technique for the treatment of chronic external otitis: how we do it</article-title>. <source>Clin Otolaryngol</source>. <year>2010</year>;<volume>35</volume>:<fpage>424</fpage>-<lpage>429</lpage>.</citation>
</ref>
<ref id="bibr6-0194599813488752">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fusconi</surname><given-names>M</given-names></name>
<name><surname>Petrozza</surname><given-names>V</given-names></name>
<name><surname>Taddei</surname><given-names>AR</given-names></name>
<etal/>
</person-group>. <article-title>Is biofilm the cause of chronic otitis externa?</article-title> <source>Laryngoscope</source>. <year>2011</year>;<volume>121</volume>:<fpage>2626</fpage>-<lpage>2633</lpage>.</citation>
</ref>
<ref id="bibr7-0194599813488752">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neu</surname><given-names>TR</given-names></name>
<name><surname>Van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
<name><surname>Dijk</surname><given-names>F</given-names></name>
<name><surname>Verkerke</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>Biodeterioration of medical-grade silicone rubber used for voice prostheses: a SEM study</article-title>. <source>Biomaterials</source>. <year>1993</year>;<volume>14</volume>:<fpage>459</fpage>-<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr8-0194599813488752">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gallo</surname><given-names>A</given-names></name>
<name><surname>de Vincentiis</surname><given-names>M</given-names></name>
<name><surname>Manciocco</surname><given-names>V</given-names></name>
<name><surname>Simonelli</surname><given-names>M</given-names></name>
<name><surname>Fiorella</surname><given-names>ML</given-names></name>
<name><surname>Shah</surname><given-names>JP</given-names></name>
</person-group>. <article-title>CO<sub>2</sub> laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases</article-title>. <source>Laryngoscope</source>. <year>2002</year>;<volume>112</volume>:<fpage>370</fpage>-<lpage>374</lpage>.</citation>
</ref>
<ref id="bibr9-0194599813488752">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Virgilio</surname><given-names>A</given-names></name>
<name><surname>Fusconi</surname><given-names>M</given-names></name>
<name><surname>Gallo</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>The oncologic radicality of supracricoid partial laryngectomy with cricohyoidopexy in the treatment of advanced N0-N1 laryngeal squamous cell carcinoma</article-title>. <source>Laryngoscope</source>. <year>2012</year>;<volume>122</volume>:<fpage>826</fpage>-<lpage>833</lpage>.</citation>
</ref>
<ref id="bibr10-0194599813488752">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carretta</surname><given-names>A</given-names></name>
<name><surname>Casiraghi</surname><given-names>M</given-names></name>
<name><surname>Melloni</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Montgomery T-tube placement in the treatment of benign tracheal lesions</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2009</year>;<volume>36</volume>:<fpage>352</fpage>-<lpage>356</lpage>.</citation>
</ref>
<ref id="bibr11-0194599813488752">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>YH</given-names></name>
<name><surname>Wu</surname><given-names>YC</given-names></name>
<name><surname>Hsieh</surname><given-names>MJ</given-names></name>
<name><surname>Ko</surname><given-names>PJ</given-names></name>
<name><surname>Liu</surname><given-names>HP</given-names></name>
<name><surname>Lin</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>Montgomery T-tube insertion using a rigid bronchoscope under direct observation</article-title>. <source>ANZ J Surg</source>. <year>2006</year>;<volume>76</volume>:<fpage>853</fpage>-<lpage>854</lpage>.</citation>
</ref>
<ref id="bibr12-0194599813488752">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sadiq</surname><given-names>Z</given-names></name>
<name><surname>Cascarini</surname><given-names>L</given-names></name>
<name><surname>Norris</surname><given-names>PM</given-names></name>
</person-group>. <article-title>Trans-tracheostomy suction technique to reduce lower airway contamination from oropharyngeal secretions</article-title>. <source>Br J Oral Maxillofac Surg</source>. <year>2010</year>;<volume>48</volume>:<fpage>388</fpage>.</citation>
</ref>
<ref id="bibr13-0194599813488752">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saldarriaga Fernández</surname><given-names>IC</given-names></name>
<name><surname>Da</surname><given-names>Silva</given-names></name>
<name><surname>Domingues</surname><given-names>JF</given-names></name>
<name><surname>van Kooten</surname><given-names>TG</given-names></name>
<etal/>
</person-group>. <article-title>Macrophage response to staphylococcal biofilms on crosslinked poly(ethylene) glycol polymer coatings and common biomaterials in vitro</article-title>. <source>Eur Cell Mater</source>. <year>2011</year>;<volume>21</volume>:<fpage>73</fpage>-<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr14-0194599813488752">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arweiler-Harbeck</surname><given-names>D</given-names></name>
<name><surname>Sanders</surname><given-names>A</given-names></name>
<name><surname>Held</surname><given-names>M</given-names></name>
<name><surname>Jerman</surname><given-names>M</given-names></name>
<name><surname>Ehrich</surname><given-names>H</given-names></name>
<name><surname>Jahnke</surname><given-names>K</given-names></name>
</person-group>. <article-title>Does metal coating improve the durability of silicone rubber voice prosthesis?</article-title> <source>Acta Otolaryngol</source>. <year>2001</year>;<volume>121</volume>:<fpage>643</fpage>-<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr15-0194599813488752">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Everaert</surname><given-names>E</given-names></name>
<name><surname>Mahieu</surname><given-names>H</given-names></name>
<name><surname>Reitsma</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>In vitro and in vivo microbial adhesion and growth on argon plasma treated silicone rubber voice prostheses</article-title>. <source>J Mater Sci Mater Med</source>. <year>1998</year>;<volume>9</volume>:<fpage>147</fpage>-<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr16-0194599813488752">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Everaert</surname><given-names>E</given-names></name>
<name><surname>Mahieu</surname><given-names>H</given-names></name>
<name><surname>Van</surname><given-names>de</given-names></name>
<name><surname>Belt-Gritter</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Biofilm formation in vivo on perfluoro-alkylsiloxane-modified voice prostheses</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>1999</year>;<volume>125</volume>:<fpage>1329</fpage>-<lpage>1332</lpage>.</citation>
</ref>
<ref id="bibr17-0194599813488752">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Angelova</surname><given-names>N</given-names></name>
<name><surname>Hunkeler</surname><given-names>D</given-names></name>
</person-group>. <article-title>Rationalizing the design of polymeric biomaterials</article-title>. <source>Trends Biotechnol</source>. <year>1999</year>;<volume>17</volume>:<fpage>409</fpage>-<lpage>421</lpage>.</citation>
</ref>
<ref id="bibr18-0194599813488752">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodrigues</surname><given-names>LR</given-names></name>
<name><surname>Van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Teixeira</surname><given-names>J</given-names></name>
<name><surname>Oliveira</surname><given-names>R</given-names></name>
</person-group>. <article-title>Influence of biosurfactants from probiotic bacteria on formation of biofilms on voice prostheses</article-title>. <source>Appl Environ Microbiol</source>. <year>2004</year>;<volume>70</volume>:<fpage>4408</fpage>-<lpage>4410</lpage>.</citation>
</ref>
<ref id="bibr19-0194599813488752">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buijssen</surname><given-names>KJ</given-names></name>
<name><surname>Harmsen</surname><given-names>HJ</given-names></name>
<name><surname>van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
<name><surname>van der Laan</surname><given-names>BF</given-names></name>
</person-group>. <article-title>Lactobacilli: important in biofilm formation on voice prostheses</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2007</year>;<volume>137</volume>:<fpage>505</fpage>-<lpage>507</lpage>.</citation>
</ref>
<ref id="bibr20-0194599813488752">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
<name><surname>Bruinsma</surname><given-names>G</given-names></name>
<name><surname>Van Weissenbruch</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>The effect of buttermilk consumption on biofilm formation on silicone rubber voice prostheses in an artificial throat</article-title>. <source>Eur Arch Otorhinolaryngol</source>. <year>1998</year>;<volume>255</volume>:<fpage>410</fpage>-<lpage>413</lpage>.</citation>
</ref>
<ref id="bibr21-0194599813488752">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Free</surname><given-names>RH</given-names></name>
<name><surname>Elving</surname><given-names>G</given-names></name>
<name><surname>Van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Van Weissenbruch</surname><given-names>R</given-names></name>
<name><surname>Albers</surname><given-names>FWJ</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Caffeinated soft drinks reduce bacterial prevalence in voice prosthetic biofilms</article-title>. <source>Biofouling</source>. <year>2000</year>;<volume>16</volume>:<fpage>69</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr22-0194599813488752">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauters</surname><given-names>T</given-names></name>
<name><surname>Moerman</surname><given-names>M</given-names></name>
<name><surname>Vermeersch</surname><given-names>H</given-names></name>
<name><surname>Nelis</surname><given-names>H</given-names></name>
</person-group>. <article-title>Colonization of voice prostheses by albicans and non-albicans Candida species</article-title>. <source>Laryngoscope</source>. <year>2002</year>;<volume>112</volume>:<fpage>708</fpage>-<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr23-0194599813488752">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elving</surname><given-names>G</given-names></name>
<name><surname>Van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
<name><surname>Amerongen</surname><given-names>A</given-names></name>
<name><surname>Veerman</surname><given-names>E</given-names></name>
</person-group>. <article-title>Antimicrobial activity of synthetic salivary peptides against voice prosthetic microrganisms</article-title>. <source>Laryngoscope</source>. <year>2000</year>;<volume>110</volume>:<fpage>321</fpage>-<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr24-0194599813488752">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pinedo-Onofre</surname><given-names>JA</given-names></name>
<name><surname>Téllez-Becerra</surname><given-names>JL</given-names></name>
<name><surname>Patiño-Gallegos</surname><given-names>H</given-names></name>
<name><surname>Miranda-Franco</surname><given-names>A</given-names></name>
<name><surname>Lugo-Alvarez</surname><given-names>G</given-names></name>
</person-group>. <article-title>Subglottic stenosis above tracheal stoma: technique for Montgomery T-tube insertion</article-title>. <source>Ann Thorac Surg</source>. <year>2010</year>;<volume>89</volume>:<fpage>2044</fpage>-<lpage>2046</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>